Department of Intensive Care Medicine, Fiona Stanley Hospital, Murdoch, Australia.
School of Medicine, University of Notre Dame, Fremantle, Australia.
Anaesthesiol Intensive Ther. 2022;54(1):30-33. doi: 10.5114/ait.2022.113488.
Non-invasive ventilation is a well-established treatment modality in patients with respiratory failure of different aetiologies. A previous case report described how non-invasive ventilation caused gastric distension and intra-abdominal hypertension with subsequent cardio-respiratory arrest and clinical recovery following resuscitative efforts including gastric decompression with a nasogastric tube.
The aim of this prospective multicentre observational study was to assess the effect of non-invasive ventilation on intra-abdominal pressure. Following informed consent, intra-abdominal pressure and PaCO2 were measured before and after the application of non-invasive ventilation for up to three days in critically ill patients requiring non-invasive ventilation.
Thirty-five patients were enrolled; mean (±SD) age of 67.8 (±12.5) years, median (interquartile range) body mass index of 27.9 (24.5-30.0) kg m-2, Acute Physiology and Chronic Health Evaluation II score of 15.8 (±6.4). On admission and after 24 hours of non-invasive ventilation, intra-abdominal pressure was 11.0 (7.5-15.0) mm Hg and 11.0 (8.5-14.5) mm Hg (P = 0.82) and PaCO2 was 44.4 (±11.4) mm Hg and 51.3 (±14.3) mm Hg (P = 0.19), respectively.
The application of non-invasive ventilation was not associated with an increase in intra-abdominal pressure over 72 hours in this small observational study. Thus, it appears that intra-abdominal pressure does not frequently increase when applying non-invasive ventilation in critically ill patients with respiratory failure.
无创通气是治疗不同病因呼吸衰竭患者的一种成熟治疗方式。先前有个案报告描述了无创通气如何导致胃扩张和腹腔内高压,随后出现心肺骤停,并通过包括鼻胃管减压在内的复苏措施恢复临床心跳呼吸。
本前瞻性多中心观察性研究旨在评估无创通气对腹腔内压的影响。在获得知情同意后,对需要无创通气的危重患者,在应用无创通气最多 3 天的前后,测量腹腔内压和 PaCO2。
共纳入 35 例患者;平均(±标准差)年龄 67.8(±12.5)岁,中位数(四分位距)体重指数 27.9(24.5-30.0)kg/m2,急性生理学和慢性健康评估 II 评分 15.8(±6.4)。入院时和接受无创通气 24 小时后,腹腔内压分别为 11.0(7.5-15.0)mmHg 和 11.0(8.5-14.5)mmHg(P = 0.82),PaCO2 分别为 44.4(±11.4)mmHg 和 51.3(±14.3)mmHg(P = 0.19)。
在本小型观察性研究中,72 小时内无创通气应用与腹腔内压升高无关。因此,在有呼吸衰竭的危重患者中应用无创通气时,似乎不会经常导致腹腔内压升高。